US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Shattuck Labs Inc (STTK)
Shattuck Labs Inc (STTK) ニュース

STTK

Shattuck Labs (STTK)

Shattuck Labs Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:STTK

1 2 3 4 5 6 7 8 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/06	20 : 30	GlobeNewswire Inc.	Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Mye	NASDAQ:STTK	Shattuck Labs Inc
2024/05/15	05 : 15	GlobeNewswire Inc.	Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the Eu	NASDAQ:STTK	Shattuck Labs Inc
2024/05/15	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/05/02	20 : 05	GlobeNewswire Inc.	Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business Highlights	NASDAQ:STTK	Shattuck Labs Inc
2024/04/10	05 : 05	GlobeNewswire Inc.	Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024	NASDAQ:STTK	Shattuck Labs Inc
2024/04/01	20 : 00	GlobeNewswire Inc.	Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference	NASDAQ:STTK	Shattuck Labs Inc
2024/03/09	07 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/03/09	07 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/03/09	07 : 29	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/03/07	06 : 42	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/03/04	21 : 14	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STTK	Shattuck Labs Inc
2024/03/04	21 : 00	GlobeNewswire Inc.	Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of Directors	NASDAQ:STTK	Shattuck Labs Inc
2024/03/01	06 : 41	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:STTK	Shattuck Labs Inc
2024/03/01	06 : 23	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	NASDAQ:STTK	Shattuck Labs Inc
2024/03/01	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STTK	Shattuck Labs Inc
2024/03/01	06 : 05	GlobeNewswire Inc.	Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business Highlights	NASDAQ:STTK	Shattuck Labs Inc
2024/02/26	21 : 00	GlobeNewswire Inc.	Shattuck Labs Announces Participation in Upcoming March Conferences	NASDAQ:STTK	Shattuck Labs Inc
2024/02/14	19 : 06	PR Newswire (US)	Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion Proteins	NASDAQ:STTK	Shattuck Labs Inc
2024/02/13	20 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:STTK	Shattuck Labs Inc
2024/02/13	20 : 00	GlobeNewswire Inc.	Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory Diseases	NASDAQ:STTK	Shattuck Labs Inc
2024/02/03	06 : 32	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:STTK	Shattuck Labs Inc
2024/02/01	14 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:STTK	Shattuck Labs Inc
2024/02/01	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/02/01	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/02/01	06 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/01/25	06 : 31	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:STTK	Shattuck Labs Inc
2024/01/17	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/01/17	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/01/17	06 : 35	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc
2024/01/17	06 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:STTK	Shattuck Labs Inc

Showing the most relevant articles for your search:NASDAQ:STTK

1 2 3 4 5 6 7 8 次へ >>

US Dollar vs Euro

Gold vs US Dollar

US Dollar vs Sterling

Health Care Select Sector

Verizon Communications

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約